APA (7th ed.) Citation

He, X., Yu, J., & Shi, H. (2021). Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

He, Xiujing, Jing Yu, and Hubing Shi. Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

He, Xiujing, et al. Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A, 2021.